Ann: Quarterly Results and Investor Conference Call Notification, page-17

I urge as many shareholders as possible to attend the conference call even if they don't ask any questions. I agree that most questions are going to be met with something along the lines of "the confidentiality agreement prevents us answering that question" or "the Scheme documents preclude my answering the question".

A legitimate question to ask is what revenue forecasts are as we require an indication so that we can make an educated decision as to whether or not to accept Pfizer's offer.